Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-08-23

Clinical Trial Update: Efficacy and Safety of High-dose Ivermectin for Reducing Malaria Transmission: A Dose Finding Study [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating efficacy and safety of high-dose ivermectin for reducing malaria transmission.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: Liverpool School of Tropical Medicine | Conditions: Malaria | Phase 2 | Status: COMPLETED